IP Library Granted Patent US 10,001,482
Granted Patent B2
US 10,001,482 · App. 14/084,973 · Granted Jun 19, 2018

Device for the detection of an analyte in a fluid sample

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,001,482
App. No.
14/084,973
Granted
Jun 19, 2018
Kind
B2
Abstract

More particularly, the present invention relates to a method for the detection of a target, e.g. pathogen in a human body fluid wherein a body fluid sample is collected with a swab member.

Claims (37)

1. A device for the detection of an analyte in an ocular fluid sample comprising:

a lateral flow chromatographic test strip comprising:

a sample application zone;

a detection zone located downstream of the sample application zone;

a conjugate zone located upstream of the detection zone, wherein the conjugate zone comprises at least one labeled binding partner able to migrate with an elution medium;

a housing containing the lateral flow chromatographic test strip and having a sample application window and a read out window; and

a swab member comprising a swab member body having a body opening and a sample collection material extending from the swab member body for collecting the ocular fluid sample;

wherein the lateral flow chromatographic test strip, the housing, and the swab member are formed such that when the lateral flow test strip is contained in the housing and the sample collection material is inserted through the sample application window, the body opening of the swab member body corresponds to the read out window, and the sample collection material is in fluid communication with the sample application zone to transfer the ocular fluid sample from the swab member to the sample application zone;

wherein the at least one labeled binding partner comprises a conjugate of gold particles and an anti-Hexon antibody; and

wherein, when the analyte is present in the ocular fluid sample, the labeled binding partner complexes with the analyte and then migrates to the detection zone.

2. The device of claim 1 , wherein the lateral flow chromatographic test strip further comprises an absorbent pad for the application of the elution medium to transfer the ocular fluid sample from the sample application zone to the detection zone, wherein the absorbent pad is located upstream from the sample application zone and the detection zone.

3. The device of claim 1 , wherein the lateral flow chromatographic test strip further comprises a waste zone downstream from the detection zone.

4. The device of claim 1 , wherein the lateral flow chromatographic test strip further comprises a carrier backing under the sample application zone, the detection zone, and the conjugate zone.

5. The device of claim 1 , wherein the detection zone contains an immobilized specific binding partner, wherein the immobilized specific binding partner binds to the analyte.

6. The device of claim 1 , wherein the detection zone further comprises a control line containing an immobilized specific binding partner, wherein the immobilized specific binding partner binds the labeled binding partner and indicates the functionality of the device.

7. The device of claim 1 , wherein the swab member collects a sample volume of the ocular fluid sample of about 0.1 μl to about 100 μl.

8. The device of claim 7 , wherein the sample volume is about 0.5 μl to about 10 μl.

9. The device of claim 7 , wherein the sample volume is 0.2 μl to 20 μl.

10. The device of claim 1 , wherein the swab member is sterile.

11. The device of claim 1 , wherein the sample collection material is selected from the group consisting of highly purified cotton fibers, polyester fibers, rayon fibers, calcium alginate fibers, polyamide fibers, and a fibrous polymeric material.

12. The device of claim 1 , wherein the sample collection material and the material of the sample application zone are selected to provide fluid communication between the sample collection material and the sample application zone to transfer the ocular fluid sample from the swab member to the sample application zone without dilution.

13. A device for the detection of an analyte in an ocular fluid sample comprising:

a lateral flow chromatographic test strip comprising:

a sample application zone;

a detection zone located downstream of the sample application zone; and

a conjugate zone located upstream of the detection zone, wherein the conjugate zone comprises at least one labeled binding partner able to migrate with an elution medium;

a housing containing the lateral flow chromatographic test strip; and

a swab member comprising a plastic swab member body having a body opening which corresponds to the read out window and a sample collection material extending from the swab member body for collecting the ocular fluid sample, wherein the sample collection material is fixed to the swab member body by ultrasonic welding;

wherein the sample collection material and the sample application zone are selected to provide fluid communication between the sample collection material and the sample application zone to transfer the ocular fluid sample from the swab member to the sample application zone without dilution;

wherein the at least one labeled binding partner comprises a conjugate of gold particles and an anti-Hexon antibody; and

wherein, when the analyte is present in the ocular fluid sample, the labeled binding partner complexes with the analyte and then migrates to the detection zone.

14. The device of claim 13 , wherein the lateral flow chromatographic test strip further comprises an absorbent pad for the application of the elution medium to transfer the ocular fluid sample from the sample application zone to the detection zone, wherein the absorbent pad is located upstream from the sample application zone and the detection zone.

15. The device of claim 13 , wherein the swab member collects a sample volume of the ocular fluid sample of about 0.1 μl to about 100 μl.

16. The device of claim 1 , wherein the swab member body is plastic and the sample collection material is fixed to the swab member body by ultrasonic welding.

17. The device of claim 5 , wherein the immobilized specific binding partner is a Hexon specific antibody.

18. The device of claim 13 , wherein the detection zone contains an immobilized specific binding partner, wherein the immobilized specific binding partner binds to the analyte.

19. The device of claim 18 , wherein the immobilized specific binding partner is a Hexon specific antibody.

Assignments (11)
RELEASE (REEL 060220 / FRAME 0711) Recorded Aug 22, 2025
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
Reel/Frame 072577/0536 →
SECURITY AGREEMENT Recorded Aug 22, 2025
From: CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; QUIDEL CARDIOVASCULAR INC.
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 072526/0643 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2024
From: QUIDEL CORPORATION
To: ORTHO-CLINICAL DIAGNOSTICS, INC.
Reel/Frame 068657/0827 →
RELEASE OF SECURITY INTEREST Recorded May 31, 2022
From: BANK OF AMERICA, N.A.
To: QUIDEL CORPORATION
Reel/Frame 060220/0649 →
SECURITY AGREEMENT Recorded May 31, 2022
From: QUIDEL CORPORATION; BIOHELIX CORPORATION; DIAGNOSTIC HYBRIDS, INC.; QUIDEL CARDIOVASCULAR INC.; ORTHO-CLINICAL DIAGNOSTICS, INC.; CRIMSON U.S. ASSETS LLC; CRIMSON INTERNATIONAL ASSETS LLC; MICRO TYPING SYSTEMS, INC.
To: BANK OF AMERICA, N.A.
Reel/Frame 060220/0711 →
RELEASE OF SECURITY INTEREST Recorded Dec 20, 2018
From: ROS ACQUISITION OFFSHORE LP
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 047834/0367 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 23, 2017
From: RAPID PATHOGEN SCREENING, INC.
To: QUIDEL CORPORATION
Reel/Frame 043926/0997 →
SECURITY INTEREST Recorded Oct 6, 2017
From: QUIDEL CORPORATION
To: BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 044141/0686 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 27, 2017
From: RAPID PATHOGEN SCREENING, INC.
To: QUIDEL CORPORATION
Reel/Frame 042829/0532 →
SECURITY INTEREST Recorded Oct 10, 2014
From: RAPID PATHOGEN SCREENING, INC.
To: ROS ACQUISITION OFFSHORE LP
Reel/Frame 033929/0786 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2014
From: ABERL, FRANZ; SCHEIBENZUBER, MARCUS; SAMBURSKY, ROBERT P; VANDINE, ROBERT; SAMBURSKY, JOSE S
To: RAPID PATHOGEN SCREENING, INC.
Reel/Frame 033545/0508 →